Glenmede Investment Management, LP Eli Lilly & CO Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Glenmede Investment Management, LP holds 314,370 shares of LLY stock, worth $322 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
314,370
Previous 310,958
1.1%
Holding current value
$322 Million
Previous $242 Billion
99.9%
% of portfolio
1.2%
Previous 1.23%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,509Shares Held
756MCall Options Held
16.8MPut Options Held
13M-
Lilly Endowment Inc Indianapolis, IN95.5MShares$97.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA81MShares$83 Billion0.96% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$67.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$52.7 Billion24.16% of portfolio
-
State Street Corp Boston, MA34.7MShares$35.6 Billion0.95% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $974B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...